Marpai, Inc. · OTC:MRAI
Marpai — Investor Presentation (December 2022)
19 slides from Marpai's investor presentation, Dec 22, 2022
Slide 1: Company Presentation December 2022
December 2022 Company Presentation | MarpaiHealth.com (NASDAQ: MRAI) Exhibit 99.1
Slide 2: Forward Looking Statements
| 2 Forward Looking Statements This presentation and the statements of representatives and partners of Marpai, Inc. (the “Company”) related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other U.S. Federal secu
Slide 3: Building the Health Plan of the Future
We use advanced AI, predictive analytics and SMART automation with the goal of reducing costs for employers while increasing health outcomes for their employees. Building the Health Plan of the Future HEALTH COSTS
Slide 4: Total addressable market for TPA fees from self-insured employers
Total addressable market for TPA fees from self-insured employers3 % of employers offering self-insured health plans which requires a TPA – Third Party Administrator2 Spending by self-insured health plans is one-third of total healthcare in America1 Employer Health Plans Cover 165 MILLION Americans
Slide 5: Exclusive AI-Powered Products
EXCLUSIVE AI-POWERED PRODUCTS Driving Member Health Up & Health Plans Costs Down Improve efficiency and eliminate errors, fraud, waste and abuse Prescription medication savings and transparency Ecosystem of VBC vendors and providers that guarantees quality AI-powered predictions and matching of memb
Slide 6: Proactively Targeting At-Risk Members for Early Intervention
Proactively Targeting At-Risk Members for Early Intervention Data-driven, Multi-channel Member Activation Data Outreach Channels Measurement and Follow Ups to Non-Responsive Members Models (Rule Based/AI)
Slide 7: Marpai Clinical Matchmaking
AI Using Claims & Other Data Matching Members to Proven Clinical Solutions Starting with Diabetes High Potential At-Risk Members At-Risk Members Diabetes Partner | 7 Marpai Clinical Matchmaking Leveraging AI & Tech to Identify Risk and Potential for Improved Outcomes
Slide 8: Marpai Clinical Services Ecosystem: Proven to Reverse Type 2 Diabetes
94% 60% PROVEN TO REVERSE TYPE 2 DIABETES patients are off all diabetes-specific drugs and living diabetes-free after 1 year patients end or reduce insulin usage after 1 year Focus on whole member health Reduces excessive and avoidable care across all chronic conditions Coming in 2023 Cardiovascular
Slide 9: Marpai and Maestro Health
MARPAI %e¢ ) cy maestro health”
Slide 10: Acquisition of Maestro Health Doubles Size of Marpai
Acquisition of Maestro Health Doubles Size of Marpai Combined Company Summary Employee Lives 40,000+ Annual Revenues $30+ million Cash on Balance Sheet $15+ million Healthcare Networks Aetna, CIGNA and more Value Added Services Marpai Rx, Clinical Care Management, Cost Containment Shared Focus Perso
Slide 11: Maestro Health Key Facts
Closed deal on October 31, 2022 to acquire Maestro Health Corporate carve-out from AXA SA Large independent provider of TPA and benefits services founded in 2013 Primarily serves mid-market employer groups High degree of customer retention and satisfaction To date, generated substantial operating lo
Slide 12: More Solutions to Sell to Existing and Future Clients
Represents Maestro Health’s existing services Represents Marpai’s existing services More Solutions to Sell Existing and Future Clients \
Slide 13: Transaction Details
Purchase Price $22.1 million due on April 1, 2024 Payment Subject to Marpai meeting its obligations under the agreement, purchase price may be financed over 4 years by the seller with the last payment due on December 31, 2027 Cash Left on Balance Sheet $15.79 million Closing Date October 31, 2022 Tr
Slide 14: Case Study: Savings of Self-insured vs. Fully Insured Plans
32% SAVINGS Per Employee Per Month (PEPM) by changing to Marpai’s self-insured plan1 Case Study: Savings Of Self-insured Vs. Fully Insured Plans American businesses are rapidly adopting self-insured plans for their flexibility and savings Washington D.C.- based Print Shop Note: 1 $769 PEPM was Unite
Slide 15: Investment Opportunity
Investment Opportunity High Margin Tech-driven cost reduction High Revenue Growth Superior product offering Highly Differentiated Predict, Prevent and Protect PROPRIETARY ALGORITHMS TECH PLATFORM INNOVATIVE BRAND LOYAL CUSTOMERS MOAT Goal: reduce cost to 1/3 of industry Higher AI-enabled quality car
Slide 16: Capitalization
Marpai Health (NASDAQ: MRAI) Common Shares Outstanding 20,937,901 Warrants ($5.89 Weighted Average Exercise Price) 1,695,748 Options ($1.43 Weighted Average Exercise Price) 3,817,367 Fully Diluted Shares 26,451,016 Note: Figures as of December 19, 2022 Capitalization
Slide 17: Investment Summary
Predict Health States Prevent Costly Claims Organic + Acquisitions High Margin Claims Costs Highly Efficient Payer Investment Summary $22+ billion market opportunity addressed with highly differentiated AI products1 Source: 1 Company analysis based on estimated $44 PEPM x 39M employee lives (McLella
Slide 18: Seasoned Leadership Team and Board of Directors
Edmundo Gonzalez CEO Ronnie Brown COO Lutz Finger President, Product & Development Eli David Chief Science Advisor Art Hoath CRO Yoram Bibring CFO Yaron Eitan Chairman Damien Lamendola Director Gonen Antebi Director Mohsen Moazami Director Colleen DiClaudio Director Vincent Kane Director Yaron Eitan
Slide 19: What Will Be - Thank you